Cutaneous T cell lymphoma

R Dummer, MH Vermeer, JJ Scarisbrick… - Nature Reviews …, 2021 - nature.com
Primary cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of lymphomas
that present in the skin with no evidence of extracutaneous disease at the time of diagnosis …

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and …

E Olsen, E Vonderheid, N Pimpinelli… - Blood, The Journal …, 2007 - ashpublications.org
The ISCL/EORTC recommends revisions to the Mycosis Fungoides Cooperative Group
classification and staging system for cutaneous T-cell lymphoma (CTCL). These revisions …

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre …

HM Prince, YH Kim, SM Horwitz, R Dummer… - The Lancet, 2017 - thelancet.com
Background Cutaneous T-cell lymphomas are rare, generally incurable, and associated with
reduced quality of life. Present systemic therapies rarely provide reliable and durable …

[HTML][HTML] Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

R Willemze, E Hodak, PL Zinzani, L Specht, M Ladetto… - Annals of …, 2018 - Elsevier
Primary cutaneous lymphomas (PCLs) are defined as non-Hodgkin lymphomas that present
in the skin with no evidence of extracutaneous disease at the time of diagnosis. After …

Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma

EA Olsen, YH Kim, TM Kuzel, TR Pacheco… - Journal of clinical …, 2007 - ascopubs.org
Purpose To evaluate the activity and safety of the histone deacetylase inhibitor vorinostat
(suberoylanilide hydroxamic acid) in persistent, progressive, or recurrent mycosis fungoides …

Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management

RA Wilcox - American journal of hematology, 2017 - Wiley Online Library
Disease overview Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell
lymphoproliferative disorders involving the skin, the majority of which may be classified as …

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis …

W Kempf, K Pfaltz, MH Vermeer… - Blood, The Journal …, 2011 - ashpublications.org
Primary cutaneous CD30+ lymphoproliferative disorders (CD30+ LPDs) are the second
most common form of cutaneous T-cell lymphomas and include lymphomatoid papulosis …

British Association of Dermatologists and UK Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018

D Gilson, SJ Whittaker, FJ Child… - British Journal of …, 2019 - academic.oup.com
British Association of Dermatologists and UK Cutaneous Lymphoma Group guidelines for the
management of primary cutaneous lymphomas 2018 | British Journal of Dermatology | Oxford …

Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management

AC Hristov, T Tejasvi, RA Wilcox - American journal of …, 2019 - Wiley Online Library
Abstract Disease Overview Cutaneous T‐cell lymphomas (CTCL) are a heterogenous group
of T‐cell neoplasms involving the skin, the majority of which may be classified as Mycosis …

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management …

NJ Senff, EM Noordijk, YH Kim, M Bagot… - Blood, The Journal …, 2008 - ashpublications.org
Primary cutaneous B-cell lymphomas (CBCL) represent approximately 20% to 25% of all
primary cutaneous lymphomas. With the advent of the World Health Organization-European …